Safety and efficacy of Pimecrolimus in atopic dermatitis among Chinese infants: A sub-group analysis of a five-year open-label study

X Dou, L Liu, X Zhu, W Wen, C Ni, Y Zhao… - Journal of …, 2023 - Taylor & Francis
Introduction Atopic dermatitis (AD) exhibits difference in immune polarization between
Caucasians and Asian races due to which an evaluation of the efficacy and safety of …
被引用次数：1 相关文章

Safety and efficacy of Pimecrolimus in atopic dermatitis among Chinese infants: a sub-group analysis of a five-year open-label study.

X Dou, L Liu, X Zhu, W Wen, C Ni, Y Zhao… - The Journal of …, 2023 - europepmc.org
Materials and methods Patients with AD (≥ 3 months-< 12 months of age) were randomized
in a 1: 1 ratio to either PIM 1% cream or topical corticosteroids (TCS). The primary endpoint …

Safety and efficacy of Pimecrolimus in atopic dermatitis among Chinese infants: a sub-group analysis of a five-year open-label study

X Dou, L Liu, X Zhu, W Wen, C Ni… - The Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Atopic dermatitis (AD) exhibits difference in immune polarization between
Caucasians and Asian races due to which an evaluation of the efficacy and safety of …